Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Helping modern organizations thrive requires a different kind of leadership. The Executive Development Program supports high-performing managers as they step into broader leadership roles. Through an ...

The Stanford Neurosciences Interdepartmental Program (IDP) offers interdisciplinary training leading to a Ph.D. in Neuroscience. The primary goal of the program is to train students to become leaders ...

On September 12, 2025, EPA released a proposal to permanently remove program obligations for 46 source categories of the GHGRP in accordance with President Trump's Executive Order 14192, "Unleashing ...

State of Social Protection Report 2025: The 2-Billion-Person Challenge https://www.worldbank.org/en/topic/socialprotection/publication/state-of-social-protection-2025 ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...